SCHEMBL29678213

SCHEMBL29678213

CCC[C@H](NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC

nearest known ligand 0.42

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ENPEP Q07075 18/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29430145 0.91 NPY4R (0.45) ENPEP
SCHEMBL30658148 0.91 ENPEP (0.42) ENPEP
SCHEMBL31277463 0.91 ENPEP (0.46) ENPEP
SCHEMBL30303032 0.91 ENPEP (0.46) ENPEP
SCHEMBL31318675 0.89 ENPEP (0.47) ENPEP
SCHEMBL30685283 0.87 NPY4R (0.45) —
SCHEMBL30148448 0.87 NPY4R (0.48) ENPEP
SCHEMBL30148464 0.87 NPY4R (0.48) ENPEP
SCHEMBL30456269 0.87 NPY4R (0.48) ENPEP
SCHEMBL30456308 0.87 NPY4R (0.48) ENPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11773183-B2 MUC16 monoclonal antibody and uses thereof QUEST PHARMATECH INC. (CA) 2023-10-03 — — US disclosed
US-11351255-B2 Treatment of cancer with therapeutic monoclonal antibody specific for a tumor associated antigen and an immune adjuvant ONCOQUEST INC. (CA) 2022-06-07 — — US disclosed
Send feedback